Cargando…
PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
BACKGROUND: Stroke severity is worsened by recruitment of inflammatory immune cells into the brain. This process depends in part on T cell activation, in which the B7 family of co-stimulatory molecules plays a pivotal role. Previous studies demonstrated more severe infarcts in mice lacking programme...
Autores principales: | Bodhankar, Sheetal, Chen, Yingxin, Vandenbark, Arthur A, Murphy, Stephanie J, Offner, Halina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846120/ https://www.ncbi.nlm.nih.gov/pubmed/24015822 http://dx.doi.org/10.1186/1742-2094-10-111 |
Ejemplares similares
Ejemplares similares
-
Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
por: Bodhankar, Sheetal, et al.
Publicado: (2014) -
Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
por: Matejuk, Agata, et al.
Publicado: (2021) -
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015) -
RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
por: Sinha, Sushmita, et al.
Publicado: (2011) -
Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020)